{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05309928",
            "orgStudyIdInfo": {
                "id": "IRB-300008691"
            },
            "organization": {
                "fullName": "University of Alabama at Birmingham",
                "class": "OTHER"
            },
            "briefTitle": "Phase 1 Study of the Pharmacokinetics of Amoxicillin in Pregnancy",
            "officialTitle": "A Rational Approach to the Identification of New Treatment Options to Prevent Congenital Syphilis: Phase 1 Study of the Pharmacokinetics of Amoxicillin in Pregnancy",
            "therapeuticArea": [
                "Women's Health"
            ],
            "study": "phase-study-of-the-pharmacokinetics-of-amoxicillin-in-pregnancy"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-08-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-03-14",
            "studyFirstSubmitQcDate": "2022-03-24",
            "studyFirstPostDateStruct": {
                "date": "2022-04-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-27",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Jodie A. Dionne, MD",
                "investigatorTitle": "Associate Professor of Medicine; Division of Infectious Diseases",
                "investigatorAffiliation": "University of Alabama at Birmingham"
            },
            "leadSponsor": {
                "name": "University of Alabama at Birmingham",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The study design is a prospective phase I pharmacokinetic study focused on dosing of 500 mg oral amoxicillin administration in pregnant women in the 2nd and 3rd trimester.",
            "detailedDescription": "Twenty adult pregnant women in good health who are admitted for preterm premature rupture of membranes (24-34 weeks gestational age) will be enrolled in this intensive pharmacokinetic study. Basic information will be collected from the medical record including age, weight, height, pregnancy dating, medications, and allergies."
        },
        "conditionsModule": {
            "conditions": [
                "Pregnancy Related"
            ],
            "keywords": [
                "pharmacokinetics",
                "amoxicillin"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "The study design is a prospective phase I pharmacokinetic study focused on dosing of 500 mg oral amoxicillin administration in pregnant women in the 2nd and 3rd trimester.",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Amox 500 mg",
                    "type": "EXPERIMENTAL",
                    "description": "Amoxicillin 500 mg PO",
                    "interventionNames": [
                        "Drug: Amoxicillin"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Amoxicillin",
                    "description": "medication administration",
                    "armGroupLabels": [
                        "Amox 500 mg"
                    ],
                    "otherNames": [
                        "Probenecid"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change of Amoxicillin Level in Plasma during Pregnancy",
                    "description": "quantitative drug level in blood",
                    "timeFrame": "0, 1, 2, 3, 4, 6, 8 hours after medication administration"
                },
                {
                    "measure": "Amoxicillin Level in Cord Blood",
                    "description": "quantitative drug level in cord blood to calculate transplacental transfer rate for amoxicillin",
                    "timeFrame": "at delivery"
                },
                {
                    "measure": "Change of Amoxicillin Level in Plasma in the Postpartum state",
                    "description": "quantitative drug levels in blood to compare to pregnancy state values",
                    "timeFrame": "0, 1, 2, 3, 4, 6, 8 hours after medication administration"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "additional pharmacologic measures",
                    "description": "1. Maximum concentration (Cmax) in maternal serum.",
                    "timeFrame": "1-8 hours after administration"
                },
                {
                    "measure": "Additional pharmacologic measure",
                    "description": "time to maximum concentration (tmax) in maternal serum",
                    "timeFrame": "1-8 hours after administration"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Pregnant, engaged in prenatal care with a medical provider (at least one visit)\n2. Estimated gestational age 24-34 weeks\n3. Able to provide informed consent\n4. English speaking\n\nExclusion Criteria:\n\n1. Receipt of amoxicillin within the past 7 days. (Routine GBS prophylaxis with ampicillin or other antibiotic and routine surgical prophylaxis prior to cesarean with cephalexin and azithromycin 500 mg IV is allowed).\n2. Known hypersensitivity or intolerance of amoxicillin, penicillin, other beta lactam or cephalosporin antibiotics.\n3. Known renal impairment (serum creatinine \u22651.2 mg/dL).\n4. Active concomitant medications known to interact with amoxicillin: allopurinol, methotrexate, mycophenolate, immune checkpoint inhibitors (ie. pembrolizumab), tetracyclines (ie. doxycycline), vitamin K antagonists (ie. warfarin), aminoglycosides (ie. gentamicin).",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "16 Years",
            "maximumAge": "50 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jodie Dionne-Odom, MD MSPH",
                    "role": "CONTACT",
                    "phone": "12059756530",
                    "email": "jdionne@uabmc.edu"
                },
                {
                    "name": "Jamie White, MBA",
                    "role": "CONTACT",
                    "phone": "204 934 8145",
                    "email": "jcarleen@uab.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jodie Dionne, MD",
                    "affiliation": "University of Alabama at Birmingham",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "UAB",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35294",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jodie Dionne, MD",
                            "role": "CONTACT",
                            "phone": "205-975-6530",
                            "email": "jdionne@uabmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M16364",
                    "name": "Syphilis",
                    "relevance": "LOW"
                },
                {
                    "id": "M16367",
                    "name": "Syphilis, Congenital",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000658",
                    "term": "Amoxicillin"
                },
                {
                    "id": "D000011339",
                    "term": "Probenecid"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000900",
                    "term": "Anti-Bacterial Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000014528",
                    "term": "Uricosuric Agents"
                },
                {
                    "id": "D000006074",
                    "term": "Gout Suppressants"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3995",
                    "name": "Amoxicillin",
                    "asFound": "Movement",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14212",
                    "name": "Probenecid",
                    "asFound": "Confirmation of",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                }
            ]
        }
    },
    "hasResults": false
}